In a new episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Eugene Borukhovich, co-founder and COO of YourCoach Health, and Lyndi Hirsch, SVP of marketing strategy at Medisafe. Both companies specialise in digital health and, although different, entered into a partnership at the end of June.

In today’s podcast, Medable Chief Science Officer Dr. Pamela Tenaerts joins host Jonah Comstock to discuss the current state of regulations in DCTs and what’s currently lacking.

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Michael Ibara, chief data officer at Elligo Health Research, discussing AI in clinical research and its overall impact on healthcare.

In the latest episode of the podcast, pharmaphorum Editor in Chief Jonah Comstock welcomes Dr. Alvaro Pascual-Leone, a neurology professor at Harvard Medical School, to the podcast to discuss how two new potentially groundbreaking Alzheimer's drugs work, describes the differences and similarities between them, and details both their exciting potential and their potential limitations. He also talks about the need for a holistic approach to Alzhemier’s treatment and the importance of lifestyle changes and early detection in fully addressing this devastating disease.  

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with André Deschamps, formerly president of Europa Uomo, the voice of men with prostate cancer in Europe. Deschamps is now involved in the Let’s Talk Prostate Cancer (LTPC) Expert Group, as well as the Belgian society, Wij Ook (part of Europa Uomo).

Recently, pharmaphorum web editor Nicole Raleigh spoke with Herbert Altmann, head of commercialisation and access solutions Europe at PharmaLex, and Casper Paardekooper, partner at Vintura. AmerisourceBergen completed the acquisition of PharmaLex (and Vintura, which was owned by PharmaLex).

In today’s podcast, Saad Harti, founder and CEO of Legacy Healthcare, joins Editor in Chief Jonah Comstock to discuss this exciting old, yet new category.  

Editor in Chief Jonah Comstock welcomes back returning guest Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbot’s vascular business. Jennifer was on the podcast just over a year ago to talk about the importance of clinical trial diversity, and she’s back with an update on that important topic, as well as some news from Abbott in that area.

In this episode of the pharmaphorum podcast, brought to you by Advanced Clinical, Advanced Clinical’s SVP Strategic Resourcing Steve Mattas and VP of Global Talent and Client Delivery James Nyssen speak with host Jonah Comstock about findings from a recent report by their company on the current personnel dynamics in pharma.

As DTx Europe came to a close at the British Medical Association in London, pharmaphorum web editor Nicole Raleigh spoke with Digital Medicine Society (DiMe) program lead, Alex Despotovic, discussing adoption of digital therapeutics and digital technologies in general in clinical practice, and the impact of the event itself overall.